The global chronic obstructive pulmonary disease market size is calculated at USD 23.55 billion in 2025 and is expected to ...

In the modern era, respiratory health has become a focal point of wellness discussions, especially as air quality concerns ...

The global lung disease therapeutics market is on an impressive growth trajectory, projected to soar to USD 152,369.26 million by 2033, up from USD 83,398.60 million in 2023. This significant increase ...

Inflammatory markers play a pivotal role in phenotyping asthma, assessing risks, and tailoring personalised therapeutic strategies, particularly in asthma associated with allergic sensitisation ...